"Hypokalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Descriptor ID |
D007008
|
| MeSH Number(s) |
C18.452.950.565
|
| Concept/Terms |
Hypokalemia- Hypokalemia
- Hypokalemias
- Hypopotassemia
- Hypopotassemias
|
Below are MeSH descriptors whose meaning is more general than "Hypokalemia".
Below are MeSH descriptors whose meaning is more specific than "Hypokalemia".
This graph shows the total number of publications written about "Hypokalemia" by people in this website by year, and whether "Hypokalemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 2 | 3 |
| 2022 | 2 | 1 | 3 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypokalemia" by people in Profiles.
-
RRAGD-Associated Autosomal Dominant Kidney Hypomagnesemia with Cardiomyopathy: A Review on the Clinical Manifestations and Therapeutic Options. Kidney Blood Press Res. 2024; 49(1):637-645.
-
What are we waiting for? A review of early basal insulin therapy in diabetic ketoacidosis management. Am J Emerg Med. 2023 10; 72:147-150.
-
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Lancet Haematol. 2022 Sep; 9(9):e678-e688.
-
Determinants of hypokalemia following hypertonic sodium bicarbonate infusion. Pflugers Arch. 2022 06; 474(6):603-612.
-
Sodium and Potassium Dysregulation in the Patient With Cancer. Adv Chronic Kidney Dis. 2022 03; 29(2):171-179.e1.
-
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 01; 97(1):42-61.
-
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial. Lancet Oncol. 2019 10; 20(10):1432-1443.
-
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma. Am J Clin Oncol. 2019 08; 42(8):649-654.
-
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery. 2019 01; 165(1):221-227.
-
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018 06 21; 39(24):2314-2325.